1. Home
  2. EHTH vs CRDF Comparison

EHTH vs CRDF Comparison

Compare EHTH & CRDF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EHTH
  • CRDF
  • Stock Information
  • Founded
  • EHTH 1997
  • CRDF 1999
  • Country
  • EHTH United States
  • CRDF United States
  • Employees
  • EHTH N/A
  • CRDF N/A
  • Industry
  • EHTH Specialty Insurers
  • CRDF Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • EHTH Finance
  • CRDF Health Care
  • Exchange
  • EHTH Nasdaq
  • CRDF Nasdaq
  • Market Cap
  • EHTH 176.1M
  • CRDF 195.6M
  • IPO Year
  • EHTH 2006
  • CRDF N/A
  • Fundamental
  • Price
  • EHTH $5.92
  • CRDF $2.85
  • Analyst Decision
  • EHTH Buy
  • CRDF Strong Buy
  • Analyst Count
  • EHTH 4
  • CRDF 4
  • Target Price
  • EHTH $6.38
  • CRDF $12.00
  • AVG Volume (30 Days)
  • EHTH 188.3K
  • CRDF 1.6M
  • Earning Date
  • EHTH 05-06-2025
  • CRDF 05-01-2025
  • Dividend Yield
  • EHTH N/A
  • CRDF N/A
  • EPS Growth
  • EHTH N/A
  • CRDF N/A
  • EPS
  • EHTH N/A
  • CRDF N/A
  • Revenue
  • EHTH $532,409,999.00
  • CRDF $683,000.00
  • Revenue This Year
  • EHTH $1.38
  • CRDF N/A
  • Revenue Next Year
  • EHTH $8.81
  • CRDF N/A
  • P/E Ratio
  • EHTH N/A
  • CRDF N/A
  • Revenue Growth
  • EHTH 17.56
  • CRDF 39.96
  • 52 Week Low
  • EHTH $3.58
  • CRDF $2.01
  • 52 Week High
  • EHTH $11.36
  • CRDF $5.64
  • Technical
  • Relative Strength Index (RSI)
  • EHTH 34.05
  • CRDF 41.85
  • Support Level
  • EHTH $5.69
  • CRDF $2.36
  • Resistance Level
  • EHTH $6.24
  • CRDF $3.04
  • Average True Range (ATR)
  • EHTH 0.41
  • CRDF 0.24
  • MACD
  • EHTH 0.06
  • CRDF 0.03
  • Stochastic Oscillator
  • EHTH 40.41
  • CRDF 56.98

About EHTH eHealth Inc.

eHealth Inc is a company involved in private health insurance marketplace with a technology and service platform that provides consumer engagement, education and health insurance enrollment solutions. The company operates its business in two segments: Medicare which provides health insurance plans and lesser extent ancillary products such as dental and vision insurance and hospital indemnity plans, to medicare eligible consumers; and Employer and Individual provides individual and family health insurance, and small business health insurance plans and Individual Coverage Health Reimbursement Arrangements. It derives maximum revenue from Medicare Segment. All of the company's revenue is from the United States. It also has a presence in China.

About CRDF Cardiff Oncology Inc.

Cardiff Oncology Inc is a clinical-stage biotechnology company leveraging PLK1 inhibition, a well-validated oncology drug target, to develop novel therapies across a range of cancers with the greatest unmet medical need. It is focusing on clinical programs in indications such as RAS-mutated metastatic colorectal cancer ("mCRC"), as well as in investigator-initiated trials in metastatic pancreatic ductal adenocarcinoma ("mPDAC"), small cell lung cancer ("SCLC"), and triple negative breast cancer ("TNBC"). Geographically, the company only operates in the United States.

Share on Social Networks: